Seaweed

Generic name: Ascophyllum, Chlorophceae (green Algae), Chondrus Crispus (Irish Moss; Red Algae), Chondrus, Ecklonia, Fucus, Gelidium, Gracilaria, Hijikia Fusiformis (hijiki; Brown Algae), Palmaria Palmate (dulse; Red Algae), Phaeophyceae (red Algae), Porphyra (nori, Re
Brand names: Algae, Brown Algae, Brown Seaweed, Dulse/dillisk, Egg Wrack, Green Algae, Hijiki, Irish Moss/carrageenin, Kelp, Kombu/konbu, Makonbu, Nori, Red Algae, Red Seaweed, Sea Grass, Sea Lettuce, Sea Spaghetti, Seaweed, Wakame

Usage of Seaweed

The uses described in the following sections focus on all seaweed species except Laminaria. See Laminaria monograph for further information regarding its potential uses.

Due to the widespread consumption of seaweed as a food source, data from animal studies are largely irrelevant. However, despite the many purported clinical applications for seaweed preparations, only a few, small clinical trials have been conducted by a limited number of researchers.

Acne

A double-blind, vehicle-controlled study of a seaweed-derived complex in 60 males younger than 25 years supports safety and efficacy of a commercially available “anti-spot” cosmetic for reducing papules, pustules, and comedomes related to mild acne. Subjects applied the base cream, with or without the active ingredient (0.1% zinc pyrrolidone carboxylic acid and kelp-derived oligosaccharide), twice daily, and although both groups experienced a significant reduction in clinical signs, the benefit in the active treatment group was greater than the control.(Capitanio 2012)

Antiviral

A clinical study evaluated the effect of undaria seaweed among patients with active and latent herpes simplex infections. Lesion healing rates were observed to be increased in those with active infections and, in vitro, undaria inhibited the virus.(Cooper 2002) A review of in vitro studies has been published, describing the effect of sulfated seaweed polysaccharides on herpes simplex and other encapsulated viruses. The polysaccharide may form a complex, blocking the interaction of the virus and cell membranes.(Damonte 2004, Feldman 1999)

A nasal spray containing 0.12% iota-carrageenan from red seaweed administered for 7 days to children (mean age, 5 years) with acute rhinitis significantly reduced viral load, time to clearance of disease, and lowered the incidence of secondary infections with other respiratory viruses. The primary end point (total symptom score) for this randomized, double-blind, placebo-controlled study, however, was not found to be significantly different between treatment and placebo groups.(Fazekas 2012)

Biomaterials

The polysaccharides alginate and chitin derived from algae are used in dressings and as topical agents for wound management as well as to treat esophageal reflux. They are being evaluated further for use in drug delivery and tissue regeneration systems.(Nelson 207, d'Ayala 2008)

Cancer

Animal data

Numerous components of seaweeds have demonstrated varying degrees of antioxidant capability and carcinogen inhibition in vitro and in vivo, such as sulfated polysaccharides (including fucoidan), phenolic compounds (including phlorotannins and bromophenols), and the carotenoid fucoxanthin. Wakame, mekabu, and kelp were found to inhibit dimethylbenz(a)anthracene (DMBA)-induced breast, liver, and skin cancer in rats. Diets supplemented with powdered seaweeds, including Laminaria and Porphyra spp, significantly reduced the incidence of mammary and intestinal tumors in rats.(Park 2013)

Clinical data

Evidence for a preventive effect of seaweed on breast cancer is derived largely from epidemiological studies. Japanese case-control studies found seaweed to be a protective factor against colon cancer (n=100), breast cancer (n=362), and esophageal cancer.(Park 20113) Data comparing women in Japan with the United States suggest the incidence of breast cancer in both pre- and postmenopausal women is lower in Japan and has been attributed in part to higher consumption of seaweed.(Aceves 2005, Teas 2009) More specifically, the importance of co-factor foods or food interactions was described in a double-blind, randomized, placebo-controlled crossover trial in 30 healthy postmenopausal American women when the addition of 5 g/day seaweed powder (Alaria esculenta) to a diet containing 100 g/day soy powder, halved the increase in insulin-like growth factor 1 (IGF-1) caused by the soy. High levels of IGF-1 have been associated with increased risk of breast cancer in postmenopausal women.(Teas 2011)

Effects on serum and urinary estrogen levels have been demonstrated experimentally in small clinical trials, with a dose-Dependent relationship demonstrated with seaweed supplementation. This may possibly be due to modulation of colonic bacteria, resulting in increased urinary excretion of 2-hydroxyestrogen.(Teas 2009, Skibola 2004) Clinical trials are lacking.

Cardiovascular/Metabolic syndrome

Increased life expectancy is associated with the Japanese Okinawa diet consisting of low salt intake and consumption of soy beans, fish, and seaweed.(Yamori 2001) Decreases in serum cholesterol and blood pressure are associated with daily consumption of seaweed either as powder or fiber.(Teas 2009) Inhibition of adipocyte differentiation has been reported for the edible Gelidium elegans.(Kim 2019)

In a double-blind, crossover study, 62 middle-aged patients with mild hypertension were given a potassium-releasing seaweed preparation. Mean blood pressure was reduced from 112 to 101 mm Hg after ingestion of 12 g/day seaweed.(Krotkiewski 1991)

In a small study among men and women with metabolic syndrome, decreases in waist circumference (in women only) and blood pressure were demonstrated with daily consumption of 4 to 6 g dried undaria seaweed over 2 months.(Teas 2009)

In a crossover study, a seaweed-derived sodium alginate preparation decreased the mean energy intake, leading researchers to consider the contribution of energy intake to obesity.(Paxman 2008) Because dietary fiber consumption has been associated with decreased energy intake and weight reduction, a four-way double-blind, placebo-controlled, crossover trial (n = 19) evaluated the effects of a preload low- and high-volume 3% alginate extract beverage (from Laminaria hyperborea and Lessonia trabeculata) on satiety, energy intake, and gastric emptying rate in healthy Danish subjects. Satiety and fullness were significantly increased, while hunger and prospective food intake were significantly decreased with the high-volume alginate treatment versus high-volume control. A significant reduction in energy intake was documented for the low-volume, but not the high-volume, treatment. High-volume alginate preload also resulted in a significant (40%) reduction in glucose response, whereas neither treatment resulted in changes to blood pressure or heart rate.(Georg Jensen 2012) In another small trial (n = 10), a reduction in energy intake of 16.4% versus control was significantly lower following consumption of Ascophyllum nodosum 4% enriched wholemeal bread in overweight males.(Hall 2012)

A small (n = 23) randomized, double-blind, crossover study reported positive changes in post-load plasma insulin concentrations (7.9% increase), suggesting improvement in insulin sensitivity subsequent to an acute 500 g dose of brown seaweed capsules (A. nodosum and Fucus vesiculosus; at least 10% polyphenols with alginates removed) prior to ingestion of a 50 g carbohydrate test meal. No significant effect was noted on glucose response.(Paradis 2011) Although, within group decreases in insulin and C-peptide were significant after a 12-week regimen of a dieckol-rich extract from Ecklonia cava (1,500 mg/day), the only significant between-group difference observed was in postprandial glucose (P<0.05) when compared to placebo in a double-blind, randomized, controlled trial in 80 prediabetic patients.(Lee 2015)

No significant overall effect was found on lipid parameters, C-reactive protein, inflammatory markers, or habitual food consumption patterns in 80 overweight or obese participants after 8 weeks of consuming brown algae (A. nodosum) polyphenol-rich extract 400 mg/day and 8 weeks of placebo in a double-blind, randomized, crossover trial. However, a significant reduction in basal DNA damage was observed with brown algae extract in obese patients (body mass index [BMI] greater than 30; P=0.044), and overall in men (P=0.009). Total antioxidant capacity was also significantly reduced with the extract, but only in women (P=0.018). Urinary metabolomic studies of the seaweed polyphenol metabolites revealed 3 distinct groupings of low excreters (25%; less than 0.5 mmol), medium excreters (55%; 0.5 to 2 mmol), and high excreters (20%; more than 2 mmol).(Baldrick 2018) Similarly, no significant effects were observed on lipid, glucose, or insulin parameters in a double-blind, randomized, placebo-controlled trial in 78 overweight or obese Korean adults who consumed Gelidium elegans extract 1,000 mg/day or placebo for 12 weeks. However, changes from baseline in several body composition parameters were significantly improved within the extract group compared to changes experienced within the placebo group. These included improvements in mean body weight (−1.17 kg vs +0.69 kg; P<0.0001), BMI (−0.43 vs +0.26; P<0.0001), total body mass (−1.21 kg vs +0.46 kg; P<0.0001), total fat mass (−0.48 kg vs +1.08 kg; P<0.0001), visceral fat (−7.36 cm2 vs +1.45 cm2; P=0.034), suBCutaneous fat (−5.67 cm2 vs +11.63 cm2; P=0.0004), and total abdominal fat (−13.03 cm2 vs +13.08 cm2; P<0.0001) for the extract and placebo, respectively, at 12 weeks. Between-group differences in absolute measures were not significantly different.(Kim 2019)

CNS effects

Animal data

Kainate, an excitatory amino acid, has been extracted from seaweed. Researchers studying the effect of epilepsy show that animal models suggest this chemical generates seizures in the hippocampus.(Ben-Ari 2000)

Clinical data

Based on dose-dependent significant benefit in a depression animal model, the effects of U. lactuca (edible algal extract) on depression in patients with anhedonia was explored in a double-blind, randomized, placebo-controlled trial (N=90). The mean age of participants was 40.2 years, 65.1% were women, and the mean BMI was 25.2 with 38.4% overweight and 11.6% obese. Anhedonia was experienced on average 20 weeks a year, and more than 90% experienced severe episodes. Anticipatory (91.8%) and consummatory (70.6%) anhedonia were most common with the majority of events triggered by problems related to work (55.8%). Significant improvements in the psychological state were observed in both the treatment and placebo groups; however, most outcomes plateaued in the placebo group at day 28, whereas improvement continued in the algae group. On day 84, administration of U. lactuca resulted in statistically significant improvements in depressive symptoms (P=0.0389), sleep disturbance (P=0.0219), psychomotor changes (P=0.002), feelings of improvement (P=0.0114), and clinician-assessed improvements (90.9% vs 70.7%, respectively; P=0.0092) compared to placebo. Adverse events were comparable between groups, and no serious event was reported.(Allaert 2018)

GI effects

The American College of Gastroenterology (ACG) clinical guideline for the management of irritable bowel syndrome (IBS) (2021) suggests that soluble, but not insoluble, fiber be used to treat global IBS symptoms (Strong; moderate).(Lacy 2021)

Immunomodulation

It has been noted that seaweed extracts exert a stimulatory effect on B lymphocytes and macrophages, which may be used clinically for the modulation of immune responses.(Liu 1997, Shan 1999) In a randomized, placebo-controlled, double-blind study (n = 70) in elderly Japanese people living in a nursing home, 300 mg/day of mekabu fucoidan (sulfated polysaccharide seaweed extract) given 4 weeks before the 2009-2010 seasonal influenza vaccine demonstrated an immunostimulatory effect. The seaweed extract group had significantly higher B strain antibody titers at 5 weeks that were maintained over 20 weeks. Additionally, natural killer cell activity in the seaweed group was not significantly different at week 9 or 24 compared with baseline; however, it was lower at week 24 versus week 9 in the placebo group.(Negishi 2013)

Supplementation of Chlorophyll c2 (0.7 mg/day) extracted from S. horneri significantly reduced the use of rescue medication in patients with seasonal allergic rhinitis after 8 weeks compared to placebo (P=0.045) in a double-blind, randomized, controlled trial (N=66). However, no significant difference was seen at the 4-week or 12-week time point. Subgroup analysis revealed better responses for those taking the extract prior to pollen dispersal as well as in patients with class 3 or higher IgE levels to cedar pollen. No significant difference was observed between groups in quality-of-life scores at any of the 3 time points.(Fujiwara 2016)

Osteoarthritis

As a source of calcium, magnesium, Selenium, and other minerals, seaweed extracts have been evaluated in osteoarthritis. Methodological problems have limited the validity of the studies, but there may be potential value in the supplementation.(Frestedt 2009, Frestedt 2008)

Seaweed side effects

Minor gastric adverse events have been reported in some clinical studies, including soft feces and feelings of fullness after 4 to 6 g doses of dried seaweed.Teas 2009

Seaweed is a rich source of iodine. Increased serum TSH levels have been demonstrated experimentally, and goiters have been reported in Japan where seaweed is widely consumed. The goiters appear to be only cosmetics and elimination of seaweed from the diet generally leads to shrinkage or disappearance of the goiter. Iodine concentrations in seaweed, as well as in dietary supplements, vary widely. In some cases, the United States maximum safe iodine intake of 1,000 mcg/day could be exceeded easily. Whether this would prove harmful is difficult to ascertain because susceptibility to the effects of a high intake of iodine appears to vary among individuals.Miyai 2008, Teas 2007 However, a case of maternal excess iodine intake that led to transient neonatal hypothyroidism has been reported in a Korean girl. Following almost daily consumption of seaweed soup, the infant’s elevated TSH, jaundice, and markedly elevated urine iodine was considered possibly related to elevated iodine in the mother’s breast milk. Thyroid function tests normalized within a few months of the mother ceasing to eat seaweed soup.Hamby 2018 Another case of iodine-induced hypothyroidism was reported in a 13-year-old Japanese girl with anorexia nervosa. Her total daily iodine intake was 34,700 mcg/day that resulted from daily intake of Kombu kelp (20 g/day), Japanese kelp and its broth. Her thyroid function improved within a week of stopping the Kombu kelp.Kita 2019

Daily intake of kelp resulted in a false-positive elevation in serum beta-D-glucan in a 55-year-old Japanese male recipient of a bone marrow transplant. The elevation was cOnfirmed by a different assay and the patient’s beta-D-glucan levels normalized within 2 days of discontinuing his kelp consumption.Hashimoto 2017

Before taking Seaweed

Information regarding safety and efficacy in pregnancy and lactation is lacking.

Effects on serum and urinary estrogen levels have been demonstrated experimentally in small clinical trials, with a dose-dependent relationship demonstrated with seaweed supplementation.Teas 2009, Skibola 2004 An increase in menstrual cycle length has also been demonstrated with the brown kelp, Fucus vesiculosus.Skibola 2004

How to use Seaweed

Robust clinical data supporting doses of seaweed that are more effective than placebo are limited.

Depressive symptoms related to anhedonia

U. lactuca (edible algal extract) administered as a single daily dose given with the evening meal for 84 days according to patient weight; 3 capsules (130 mg/day) for patients 50 to 75 kg, 4 capsules for those 70 to 90 kg, and 5 capsules for those 90 to 110 kg.Allaert 2018

Immunomodulation

300 mg/day of mekabu fucoidan (sulfated polysaccharide seaweed extract) given 4 weeks before the seasonal influenza vaccine.Negishi 2013

Postprandial glucose in prediabetics

E. cava (1,500 mg/day) for 12 weeks.Lee 2015

Seasonal allergic rhinitis

Chlorophyll c2 (0.7 mg/day) extracted from S. horneri for 12 weeks prior to and during the pollen season.Fujiwara 2016

Warnings

Excessive intake of dried seaweed has been reported to cause carotenodermia (yellowing of the skin). Hypercarotenemia is caused by excessive intake of carotene-rich vegetables or drinks.Nishimura 1998 Arsenic is considered a human carcinogen and certain forms have been found in large amounts in seafood and seaweed; however, increases in urinary arsenic excretion have not been demonstrated in human studies.Hsueh 2002

Certain blue-green algae found in the Pacific, Indian, and Caribbean oceans have been associated with contact dermatitis. An isolate from the algae, debromoaplysiatoxin, is a very potent inflammatory agent, producing a follicular, papular, and pustular reaction in minute concentrations.Izumi 1987 Two other seaweeds, Gracilaria coronopifolia and Gracilaria tsudai, usually are considered nontoxic, but occasionally may produce poisons associated with GI symptoms when ingested. Extreme cases have resulted in death.Marshall 1998

What other drugs will affect Seaweed

Vitamin K antagonist: A single case report describes a change in INR in a patient taking warfarin who consumed a large quantity of sushi that contained seaweed. This was thought to be caused by the high vitamin K content of the seaweed. Seaweed may diminish the anticoagulant effect of vitamin K antagonists. Monitor therapy.(Bartle 2001, Daugherty 2006)

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords